Extended Fasting Research

This systematic review and meta-analysis specifically examined longer-term studies of intermittent fasting (12 weeks or more) in adults with overweight or obesity. The focus on extended duration addresses a key gap in the IF literature, where most studies are short-term.

The analysis found that IF protocols maintained over 12+ weeks produced meaningful and sustained improvements in body composition. Weight loss averaged 3-5 kg, with significant reductions in fat mass. Importantly, lean mass was largely preserved, addressing concerns that fasting might accelerate muscle loss. Cardiometabolic markers including fasting glucose, insulin, blood pressure, and some lipid parameters also improved.

The findings support IF as a sustainable long-term dietary strategy for metabolic health. The preservation of lean mass is particularly notable, suggesting that when combined with adequate protein intake during eating windows, IF does not compromise muscle mass any more than traditional caloric restriction.

This narrative review synthesized findings from human trials on prolonged water fasting (PWF), defined as water-only fasting lasting 2 or more consecutive days. The authors examined studies ranging from short-term clinical trials to observational data from fasting clinics like Buchinger Wilhelmi.

Key findings across studies included substantial weight loss (typically 0.5-1 kg per day, mostly water and glycogen initially), reductions in blood pressure, improvements in lipid profiles, and decreased fasting glucose and insulin levels. The review also examined autophagy activation and the metabolic shift to ketosis that occurs during extended fasts.

However, the authors noted significant limitations in the existing evidence base. Most studies lacked control groups, had small sample sizes, and follow-up was typically short. The review emphasized that proper medical supervision and careful refeeding protocols are essential, particularly for fasts exceeding 5-7 days, due to refeeding syndrome risk.

This umbrella review synthesized evidence from 11 systematic reviews and meta-analyses of randomized controlled trials examining intermittent fasting's effects on health outcomes. The authors used GRADE methodology to assess evidence quality and provide definitive conclusions about IF's efficacy.

The review found convincing or highly suggestive evidence that intermittent fasting reduces body weight, BMI, and fat mass compared to ad libitum eating or continuous energy restriction. Effects on cardiometabolic markers were more variable - blood pressure, fasting insulin, and insulin resistance showed improvements with moderate certainty, while effects on lipids and HbA1c were less consistent.

Importantly, the review found that IF was generally equivalent to continuous caloric restriction for weight loss, suggesting the benefits come from overall energy reduction rather than fasting-specific mechanisms. However, some individuals find IF more sustainable than daily calorie counting, which may improve long-term adherence.

This authoritative review in the New England Journal of Medicine synthesized the evidence for intermittent fasting's effects on health and aging. Written by leading researchers from the National Institute on Aging and Johns Hopkins, it provided mainstream medical credibility to fasting interventions.

The authors propose that "metabolic switching" - the shift from glucose to ketone utilization during fasting - triggers cellular adaptations that improve glucose regulation, increase stress resistance, and suppress inflammation. These effects may underlie the observed benefits in animal models and preliminary human studies.

The review concludes that while more research is needed, existing evidence supports intermittent fasting as a legitimate health intervention worthy of clinical consideration.

This study from the Buchinger Wilhelmi clinic - Europe's leading therapeutic fasting center with over a century of experience - documented outcomes from 1,422 subjects who underwent medically supervised fasting lasting 4 to 21 days.

The fasting protocol involved 200-250 kcal/day from juice and vegetable broth, with medical monitoring throughout. Results showed significant improvements in weight, blood pressure, blood lipids, and subjective well-being, with minimal adverse events.

The large sample size and real-world clinical setting provide valuable safety and efficacy data for extended fasting under medical supervision.

This study from Valter Longo's lab at USC tested whether periodic cycles of a fasting-mimicking diet (FMD) could reduce risk factors for age-related diseases in humans. The FMD provides specific nutrients while triggering fasting-like metabolic responses.

Three monthly cycles of the 5-day FMD reduced body weight, trunk fat, blood pressure, and IGF-1 (a growth factor associated with aging and cancer risk). Effects were most pronounced in participants who started with elevated risk factors.

This study helped establish periodic extended fasting (or fasting-mimicking) as a potential intervention for healthspan and disease prevention.

This groundbreaking study from Valter Longo's USC lab demonstrated that prolonged fasting triggers regeneration of the immune system through stem cell activation. The research showed that fasting lowered IGF-1 and PKA signaling, which in turn promoted hematopoietic stem cell self-renewal.

The study found that cycles of prolonged fasting (48-72 hours in mice, equivalent to several days in humans) protected against chemotherapy-induced immunosuppression and promoted immune system regeneration. The mechanism involved killing old, damaged immune cells and triggering stem cells to create new ones.

This study provided mechanistic support for extended fasting as a potential intervention for immune system health and regeneration.